Ayala Pharmaceuticals Inc (ADXS)
0.57
-0.08
(-11.70%)
USD |
OTCM |
Apr 18, 15:33
Ayala Pharmaceuticals Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2022 | -0.103M |
| September 30, 2022 | 4.459M |
| June 30, 2022 | 9.791M |
| March 31, 2022 | 9.732M |
| December 31, 2021 | 33.33M |
| September 30, 2021 | 29.64M |
| June 30, 2021 | 24.14M |
| Date | Value |
|---|---|
| March 31, 2021 | 76.82M |
| December 31, 2020 | 52.92M |
| September 30, 2020 | 52.58M |
| June 30, 2020 | 52.28M |
| March 31, 2020 | 3.619M |
| December 31, 2019 | 7.075M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.103M
Minimum
Dec 2022
76.82M
Maximum
Mar 2021
27.41M
Average
24.14M
Median
Jun 2021
Cash from Financing (TTM) Benchmarks
| Taro Pharmaceutical Industries Ltd | 0.00 |
| InspireMD Inc | 37.53M |
| BiomX Inc | 2.899M |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | -- |